Orna Therapeutics
Orna Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, is a biotechnology company reshaping RNA therapeutics. We are developing the leading circular RNA technology platform (oRNA®) and unprecedented lipid nanoparticle (LNP) delivery solutions – unlocking the therapeutic possibilities of circular RNA and pioneering the next chapter of safe and effective in vivo therapies for the treatment of disease. Website: www.ornatx.comwww.ornatx.com
2
MENTIONS
2
EPISODES
2
PODCASTS
Search complete. 2 mentions across 2 episodes found for "Orna Therapeutics".
Nov 3, 2026
Erik WiklundGUEST
The first clinical data published was actually just yesterday by a Chinese company, Ribox, published in New England Medical Journal, data from their first clinical trial.
Erik WiklundGUEST
We have Orna Therapeutics through the Lilly, after the Lilly acquisition now in the clinic.
Erik WiklundGUEST
So we have the first couple of RNAs, circular RNAs are now generating and will generate clinical data in rapid succession.
Erik WiklundGUEST
But we have to admit it's all early.
Thomas HansenGUEST
I guess you could say
Erik WiklundGUEST
that day in the lab you're referring to I think maybe was 2008 or 2009 That directly led to these acquisitions this year by, for example, Eli Lilly acquiring Orna Therapeutics for $2.4 billion.
Erik WiklundGUEST
It's a consequence of that particular discovery on that day.
CallumHOST
There's been some pretty good examples of science going in unexpected directions in history and leading to some pretty good outcomes.